Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Study Evaluating Single Dose Of ILV-095 In Psoriasis Subjects

Phase 1

Terminated

Conditions: Plaque Psoriasis

Interventions: Drug: ILV-095 300 mg in a 4 to 1 ratio

First Posted Date: 2009-11-10

Last Posted Date: 2024-07-03

Lead Sponsor: Pfizer

Target Recruit Count: 39

Registration Number: NCT01010542

Locations: 🇨🇦
K. Papp Clinical Research, Waterloo, Ontario, Canada
🇺🇸
MRA Clinical Research, South Miami, Florida, United States
🇺🇸
Radiant Research, Inc., Greer, South Carolina, United States

and more 6 locations

Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis

Phase 2

Completed

Conditions: Active Rheumatoid Arthritis

Interventions: Drug: SBI-087
Drug: Placebo

First Posted Date: 2009-11-06

Last Posted Date: 2013-12-03

Lead Sponsor: Pfizer

Target Recruit Count: 210

Registration Number: NCT01008852

Locations: 🇪🇸
Pfizer Investigational Site, Sevilla, Spain

Caverject User Study

Phase 3

Completed

Conditions: Erectile Dysfunction

Interventions: Other: delivery system

First Posted Date: 2009-11-06

Last Posted Date: 2012-04-06

Lead Sponsor: Pfizer

Target Recruit Count: 48

Registration Number: NCT01008605

Locations: 🇺🇸
Pfizer Investigational Site, Overland Park, Kansas, United States

A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy

Phase 2

Completed

Conditions: Excessive Daytime Sleepiness
Narcolepsy

Interventions: Drug: Placebo
Drug: PF-03654746

First Posted Date: 2009-11-01

Last Posted Date: 2014-05-09

Lead Sponsor: Pfizer

Target Recruit Count: 95

Registration Number: NCT01006122

Locations: 🇺🇸
Pfizer Investigational Site, Houston, Texas, United States

Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers

Phase 1

Completed

Conditions: Alzheimer's Disease

Interventions: Biological: PF-04360365
Drug: Placebo

First Posted Date: 2009-11-01

Last Posted Date: 2012-09-26

Lead Sponsor: Pfizer

Target Recruit Count: 17

Registration Number: NCT01005862

Locations: 🇸🇪
Pfizer Investigational Site, Stockholm, Sweden

A Safety, Tolerability, And Pharmacokinetic Trial With CVX-241 In Patients With Advanced Solid Tumors

Phase 1

Terminated

Conditions: Advanced Solid Tumors

Interventions: Drug: CVX-241

First Posted Date: 2009-10-30

Last Posted Date: 2015-11-20

Lead Sponsor: Pfizer

Target Recruit Count: 31

Registration Number: NCT01004822

Locations: 🇺🇸
Premiere Oncology, A Medical Corporation, Santa Monica,, California, United States
🇺🇸
Premiere Oncology of Arizona, Scottsdale, Arizona, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy

Phase 1

Completed

Conditions: Eye Diseases
Retinal Degeneration
Macular Degeneration
Age-Related Maculopathy
Age-Related Maculopathies

Interventions: Biological: RN6G
Biological: Placebo

First Posted Date: 2009-10-29

Last Posted Date: 2022-05-12

Lead Sponsor: Pfizer

Target Recruit Count: 24

Registration Number: NCT01003691

Locations: 🇺🇸
Clinical Specialists, LLC, Augusta, Georgia, United States
🇺🇸
Jay Markowitz and Associates, West Columbia, South Carolina, United States
🇺🇸
American Institute of Research (Administrative Only), Los Gatos, California, United States

and more 21 locations

Muscle Malonyl Coa Biomarker Assay Development

Phase 1

Terminated

Conditions: Healthy Volunteers

Interventions: Procedure: Muscle biopsy

First Posted Date: 2009-10-28

Last Posted Date: 2010-11-24

Lead Sponsor: Pfizer

Target Recruit Count: 4

Registration Number: NCT01003444

Locations: 🇺🇸
Pfizer Investigational Site, New Haven, Connecticut, United States

A Study To Investigate The Safety And Toleration Of A Single Dose Of PF-04418948 In Healthy Volunteers

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: PF-04418948

First Posted Date: 2009-10-28

Last Posted Date: 2010-10-25

Lead Sponsor: Pfizer

Target Recruit Count: 56

Registration Number: NCT01002963

Locations: 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium

A Study To Establish The Effects Of PF-04457845 On Sleep In Healthy Volunteers

Phase 1

Terminated

Conditions: Sleep
Healthy Volunteers

Interventions: Drug: PF-04457845 / matched placebo

First Posted Date: 2009-10-27

Last Posted Date: 2010-07-08

Lead Sponsor: Pfizer

Target Recruit Count: 18

Registration Number: NCT01002625

Locations: 🇺🇸
Pfizer Investigational Site, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy